Botanix Surges 17% as Sofdra Launch Gains Momentum in the US

Market Reassesses Botanix as Q1 Data Sparks 17% Share Price Rise Botanix (ASX: BOT) appears to be entering a turnaround phase following a difficult start to the year, when unmet…

ByCharlie Youlden

09

Jul 2025

Biotech Stocks Healthcare Stocks News Small Caps Stocks

Botanix Pharmaceuticals (ASX:BOT): Did it deserve to crash over 50% earlier this week?

Botanix Pharmaceuticals (ASX:BOT) crashed over 50% back on Tuesday after an update that left investors disappointed. A crash of this magnitude would suggest the FDA knocked back its drug or…

ByNick Sundich

28

Jul 2023

Uncategorized

ASX Life Sciences stocks: Here are 2 of the best!

ASX Life Sciences stocks discussed by Stuart Roberts as interest rates peak What are the Best ASX Stocks to invest in right now? Check our buy/sell tips on the top…

ByMarc Kennis

Botanix Surges 17% as Sofdra Launch Gains Momentum in the US

Botanix Pharmaceuticals (ASX:BOT): Did it deserve to crash over 50% earlier this week?

ASX Life Sciences stocks: Here are 2 of the best!

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Botanix Surges 17% as Sofdra Launch Gains Momentum in the US

Botanix Pharmaceuticals (ASX:BOT): Did it deserve to crash over 50% earlier this week?

ASX Life Sciences stocks: Here are 2 of the best!

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Add Your Heading Text Here